Product Specifications
| Prod Model: |
080304 |
| Markets: |
South America,Southeast Asia,Africa,Mid East,Eastern Asia,Western Europe |
Product Description
Phentolamine Mesylate for Injection is indicated for the prevention or control of hypertensive episodes that may occur in a patient with pheochromocytoma as a result of stress or manipulation during preoperative preparation and surgical excision.
Phentolamine Mesylate for Injection is indicated for the prevention or treatment of dermal necrosis and sloughing following intravenous administration or extravasation of norepinephrine.
Phentolamine Mesylate for Injection is also indicated for the diagnosis of pheochromocytoma by the phentolamine blocking test.
Shanghai Xudong Haipu Pharmaceutical Co., Ltd. is the first professional injection producer in China founded in 1925. We belong to the NO. 1 Pharmaceutical Group in China-- Shanghai Pharmaceutical Group.
We own three GMP and ISO14001 certified plants in conformity to WHO requirements. We speicalize in over 100 items of different finished medications, our wide network of parthership could provide almost all of the items in pharmaceutical area. It is our professional attitude to support you in area of export packing, latest quality standard and registration.
Some of our products have been sucessfully registered and exported to Yugoslavia, Algeria, Pakistan, Egypt, Cuba, DPRK, Mali, Russia, and etc. We wish to enter a good business relations with you. Contact us as you wish at any moment.
